PLoS ONE (Jan 2015)

ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells.

  • Eloy Cuadrado,
  • Thijs Booiman,
  • John L van Hamme,
  • Machiel H Jansen,
  • Karel A van Dort,
  • Adeline Vanderver,
  • Gillian I Rice,
  • Yanick J Crow,
  • Neeltje A Kootstra,
  • Taco W Kuijpers

DOI
https://doi.org/10.1371/journal.pone.0143613
Journal volume & issue
Vol. 10, no. 12
p. e0143613

Abstract

Read online

Unlike resting CD4+ T cells, activated CD4+T cells are highly susceptible to infection of human immunodeficiency virus 1 (HIV-1). HIV-1 infects T cells and macrophages without activating the nucleic acid sensors and the anti-viral type I interferon response. Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA editing enzyme that displays antiviral activity against several RNA viruses. Mutations in ADAR1 cause the autoimmune disorder Aicardi-Goutieères syndrome (AGS). This disease is characterized by an inappropriate activation of the interferon-stimulated gene response. Here we show that HIV-1 replication, in ADAR1-deficient CD4+T lymphocytes from AGS patients, is blocked at the level of protein translation. Furthermore, viral protein synthesis block is accompanied by an activation of interferon-stimulated genes. RNA silencing of ADAR1 in Jurkat cells also inhibited HIV-1 protein synthesis. Our data support that HIV-1 requires ADAR1 for efficient replication in human CD4+T cells.